 Boston Globe | Roche to Buy Genentech For $95/Share TheStreet.com Roche agreed to purchase the remaining 44% of Genentech it doesn't already own for $95 a share - a final price that met with the approval of Genentech's board. At $95, Roche is paying $46.8 billion for its new Genentech stake and just under 7% more ... Report: Genentech, Roche negotiations held up by legal debate Roche to buy Genentech to $46.8 billion Genentech mum about selling to Roche |
Thursday, March 12, 2009
Brea NEWS - Roche to Buy Genentech For $95/Share - TheStreet.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment